Il rapporto
Notizie verificate su finanziamenti, sedi centrali e leadership delle aziende più innovative al mondo
721 report e oltre
Sirona Medical Raises $40M Series D for AI-Native Radiology Workflow Software
Sirona Medical announced a $40 million Series D financing led by Avidity Partners, with participation from 8VC, GreatPoint Ventures, KLT Holdings and other investors.
Altis Labs Raises $25M Series A for AI Clinical-Trial Endpoints
Altis Labs raised a $25 million Series A co-led by OrbiMed and Qiming Venture Partners USA to expand AI endpoints for oncology clinical trials.
Inquis Medical raises $40M Series B at $200M valuation
Inquis Medical raises $40M in Series B at $200M valuation. Medical technology company specializing in thrombectomy systems...
Capstan Medical Raises $110M Series C | Cardiac Surgical Robotics
Medical robotics company Capstan Medical secures $110 million Series C led by Eclipse Ventures.
NeuralNet Medical Raises $680M Series D to Revolutionize HealthTech
NeuralNet Medical secures $680M in Series D funding at $9.4B valuation to expand fda approvals for additional conditions, scale ai model training, and deploy in 500+ hospitals globally.
Select Medical Raises $6B in Public
Select Medical, a Healthcare company based in 4714 Gettysburg Road, Mechanicsburg, PA 17055, has raised $6B in Public at a $7B valuation led by Public.
Inquis Medical Raises $40M in Series B
Inquis Medical, a HealthTech company based in Menlo Park, CA, has raised $40M in Series B at a $200M valuation led by Marshall Wace, Cormorant Asset Management.
SetPoint Medical Raises $140M in Series D
SetPoint Medical, a HealthTech company based in Valencia, CA, has raised $140M in Series D at a $650M valuation led by Cowen Healthcare, Temasek.
Setpoint Medical Raises $200M in Series C
Setpoint Medical, a HealthTech company based in Valencia, CA, has raised $200M in Series C at a $500M valuation led by Eclipse Ventures, Alexandria Venture Investments.
Visualizzazione di 9 report • Pagina 1 • Categoria: all
Rimani avanti rispetto al mercato
Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.